Ciobotaru Vlad, Heimburger Michèle, Louedec Liliane, Heymes Christophe, Ventura-Clapier Renée, Bedossa Pierre, Escoubet Brigitte, Michel Jean-Baptiste, Mercadier Jean-Jacques, Logeart Damien
Cardiology Department, Lariboisiere Hospital, 2 rue Ambroise Pare, 75010 Paris, France.
J Pharmacol Exp Ther. 2008 Jan;324(1):43-9. doi: 10.1124/jpet.107.130237. Epub 2007 Sep 27.
We investigated the effects of long-term heart rate reduction (HRR) on pressure overload-induced heart failure. Pressure overload of the left ventricle was induced in 21-day-old rats by banding the ascending aorta. HRR was induced for 3 months with ivabradine (n = 44), a selective I(f) current inhibitor, at 10 mg/kg/day, starting 14 days after banding. Thirty-six control banded rats and 16 sham-operated rats received standard chow. Banding resulted in severe left ventricular (LV) hypertrophy (+55% versus shams; p < 0.001) and fibrosis, together with a 34% decrease (p < 0.01) in the LV shortening fraction. Heart rate decreased by 19% in ivabradine-treated rats (p < 0.005 versus controls). Stroke volume increased (by 17%; p < 0.01), whereas cardiac output did not change with HRR. In contrast, HRR resulted in 1) a marked increase in LV filling pressure (p < 0.01) and in atrial, lung, and right ventricular weights (38, 30, and 54%, respectively; p < 0.001); 2) a 50% increase in the incidence of pleural/abdominal effusion (p < 0.001); 3) 7 and 26% increases in LV hypertrophy and fibrosis, respectively (p < 0.05); and 4) a 53% increase in the atrial natriuretic peptide mRNA level compared with controls (p < 0.001). After 3 months of treatment, ivabradine withdrawal normalized the heart rate and reduced LV size and LV filling pressure (p < 0.05). In conclusion, pure longstanding HRR showed no beneficial effect on LV dysfunction in a rat model of pressure overload-induced LV hypertrophy, and it seemed to favor adverse LV remodeling and its congestive consequences.
我们研究了长期心率降低(HRR)对压力超负荷诱导的心力衰竭的影响。通过结扎升主动脉在21日龄大鼠中诱导左心室压力超负荷。在结扎后14天开始,用10mg/kg/天的伊伐布雷定(n = 44),一种选择性I(f)电流抑制剂,诱导HRR 3个月。36只对照结扎大鼠和16只假手术大鼠接受标准饲料。结扎导致严重的左心室(LV)肥厚(与假手术组相比增加55%;p < 0.001)和纤维化,同时左心室缩短分数降低34%(p < 0.01)。伊伐布雷定治疗的大鼠心率降低了19%(与对照组相比,p < 0.005)。每搏输出量增加(17%;p < 0.01),而心输出量在HRR时没有变化。相比之下,HRR导致:1)左心室充盈压显著增加(p < 0.01)以及心房、肺和右心室重量增加(分别为38%、30%和54%;p < 0.001);2)胸腔/腹腔积液发生率增加50%(p < 0.001);3)左心室肥厚和纤维化分别增加7%和26%(p < 0.05);4)与对照组相比,心房利钠肽mRNA水平增加53%(p < 0.001)。治疗3个月后,停用伊伐布雷定使心率恢复正常,并减小了左心室大小和左心室充盈压(p < 0.05)。总之,在压力超负荷诱导的左心室肥厚大鼠模型中,单纯长期的HRR对左心室功能障碍没有有益作用,而且似乎有利于不良的左心室重塑及其充血性后果。